CN109464584A - 一种治疗哮喘中西药及制备方法 - Google Patents
一种治疗哮喘中西药及制备方法 Download PDFInfo
- Publication number
- CN109464584A CN109464584A CN201811590232.1A CN201811590232A CN109464584A CN 109464584 A CN109464584 A CN 109464584A CN 201811590232 A CN201811590232 A CN 201811590232A CN 109464584 A CN109464584 A CN 109464584A
- Authority
- CN
- China
- Prior art keywords
- chinese
- western medicine
- medicine
- preparation
- inophylline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种治疗哮喘中西药及制备方法,各组分所占总重量百分比为:西药:甘草片0.10~0.60%、扑尔敏0.10~0.50%、安茶碱0.10~0.30%、新诺明0.05~0.25%、肺宝三效0.10~0.70%、强的松0.05~0.30%、酵母0.05~0.30%;中药:川贝母0.20~1.00%、桔梗0.10~0.80%、制麻黄0.10~0.40%、杏仁0.10~0.35%、桑白皮0.05~0.50%。本发明与现有技术相比的优点在于:具有治疗哮喘的功效,并具有健脾开胃合理联合用药比单用药物有优越性,既可降低药性提高疗效、减轻副作用,使药物发挥更大的疗效,因为是联合用药,所达到的治疗效果更加明显。
Description
技术领域
本发明涉及哮喘药领域,具体是指一种治疗哮喘中西药及制备方法。
背景技术
支气管由于环境的污染、气候变化异常、呼吸道疾病、接触物过敏、体质弱、免疫力低遗传等问题,现在医学目前尚无较好的预防及根治气管哮喘的药物,哮喘性支气管炎的病发率呈居高不下的状态,支气管炎是一个较顽固的病症,反复发作,今年我国中医在治疗支气管哮喘方面也进行大量工作,大多以中医制定为主尚未发现根治支气管哮喘病的药物。
发明内容
本发明要解决的技术问题是,针对以上问题提供一种能够有效预防及治疗支气管哮喘的药物。
为解决上述技术问题,本发明提供的技术方案为:一种治疗哮喘中西药及制备方法,各组分所占总重量百分比为:
西药:甘草片0.10~0.60%、扑尔敏0.10~0.50%、安茶碱0.10~0.30%、新诺明0.05~0.25%、肺宝三效0.10~0.70%、强的松0.05~0.30%、酵母0.05~0.30%;
中药:川贝母0.20~1.00%、桔梗0.10~0.80%、制麻黄0.10~0.40%、杏仁0.10~0.35%、桑白皮0.05~0.50%。
本发明与现有技术相比的优点在于:具有治疗哮喘的功效,并具有健脾开胃合理联合用药比单用药物有优越性,既可降低药性提高疗效、减轻副作用,使药物发挥更大的疗效,因为是联合用药,所达到的治疗效果更加明显。
作为改进,各组分所占总重量百分比为:
西药:甘草片0.20~0.58%、扑尔敏0.18~0.31%、安茶碱0.15~0.25%、新诺明0.12~0.20%、肺宝三效0.14~0.25%、强的松0.10~0.18%、酵母0.10~0.25%;
中药:川贝母0.30~0.75%、桔梗0.25~0.60%、制麻黄0.20~0.35%、杏仁0.15~0.30%、桑白皮0.15~0.40%。
作为改进,其制备方法为:
①按比例取西药:甘草片、扑尔敏、安茶碱、新诺明、肺宝三效和强的松精研成粉;
②加入酵母和适量的水进行发酵;
③按比例取中药:川贝母、桔梗、制麻黄、杏仁和桑白皮精研成粉后加入。
具体实施方式
本发明在具体实施时,一种治疗哮喘中西药及制备方法,各组分所占总重量百分比为:
西药:甘草片0.10~0.60%、扑尔敏0.10~0.50%、安茶碱0.10~0.30%、新诺明0.05~0.25%、肺宝三效0.10~0.70%、强的松0.05~0.30%、酵母0.05~0.30%;
中药:川贝母0.20~1.00%、桔梗0.10~0.80%、制麻黄0.10~0.40%、杏仁0.10~0.35%、桑白皮0.05~0.50%。
本发明与现有技术相比的优点在于:具有治疗哮喘的功效,并具有健脾开胃合理联合用药比单用药物有优越性,既可降低药性提高疗效、减轻副作用,使药物发挥更大的疗效,因为是联合用药,所达到的治疗效果更加明显。
作为改进,各组分所占总重量百分比为:
西药:甘草片0.20~0.58%、扑尔敏0.18~0.31%、安茶碱0.15~0.25%、新诺明0.12~0.20%、肺宝三效0.14~0.25%、强的松0.10~0.18%、酵母0.10~0.25%;
中药:川贝母0.30~0.75%、桔梗0.25~0.60%、制麻黄0.20~0.35%、杏仁0.15~0.30%、桑白皮0.15~0.40%。
作为改进,其制备方法为:
①按比例取西药:甘草片、扑尔敏、安茶碱、新诺明、肺宝三效和强的松精研成粉;
②加入酵母和适量的水进行发酵;
③按比例取中药:川贝母、桔梗、制麻黄、杏仁和桑白皮精研成粉后加入。
实施例:
实施例一:西药:甘草片0.20~0.58%、扑尔敏0.18~0.31%、安茶碱0.15~0.25%、新诺明0.12~0.20%、肺宝三效0.14~0.25%、强的松0.10~0.18%、酵母0.10~0.25%;
中药:川贝母0.30~0.75%、桔梗0.25~0.60%、制麻黄0.20~0.35%、杏仁0.15~0.30%、桑白皮0.15~0.40%。
①按比例取西药:甘草片、扑尔敏、安茶碱、新诺明、肺宝三效和强的松精研成粉;
②加入酵母和适量的水进行发酵;
③按比例取中药:川贝母、桔梗、制麻黄、杏仁和桑白皮精研成粉后加入。
实施例二:西药:甘草片0.25%、扑尔敏0.27%、安茶碱0.18%、新诺明0.16%、肺宝三效0.23%、强的松0.15%、酵母0.14%;
中药:川贝母0.62%、桔梗0.48%、制麻黄0.27%、杏仁0.19%、桑白皮0.20%。
①按比例取西药:甘草片、扑尔敏、安茶碱、新诺明、肺宝三效和强的松精研成粉;
②加入酵母和适量的水进行发酵;
③按比例取中药:川贝母、桔梗、制麻黄、杏仁和桑白皮精研成粉后加入。
混合服用,每次用药计量一2克为准,严重患者早晚各服一次,病情减轻晚服一次,直至痊愈,本发明还能够治疗感冒,对于各种疼痛都有缓解作用,利尿,对于呼吸道疾病和感冒效果极佳。
以上对本发明及其实施方式进行了描述,这种描述没有限制性,以上所示的也只是本发明的实施方式之一,实际的结构并不局限于此。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护范围。
Claims (3)
1.一种治疗哮喘中西药及制备方法,其特征在于:各组分所占总重量百分比为:
西药:甘草片0.10~0.60%、扑尔敏0.10~0.50%、安茶碱0.10~0.30%、新诺明0.05~0.25%、肺宝三效0.10~0.70%、强的松0.05~0.30%、酵母0.05~0.30%;
中药:川贝母0.20~1.00%、桔梗0.10~0.80%、制麻黄0.10~0.40%、杏仁0.10~0.35%、桑白皮0.05~0.50%。
2.根据权利要求1所述的一种治疗哮喘中西药,其特征在于:各组分所占总重量百分比为:
西药:甘草片0.20~0.58%、扑尔敏0.18~0.31%、安茶碱0.15~0.25%、新诺明0.12~0.20%、肺宝三效0.14~0.25%、强的松0.10~0.18%、酵母0.10~0.25%;
中药:川贝母0.30~0.75%、桔梗0.25~0.60%、制麻黄0.20~0.35%、杏仁0.15~0.30%、桑白皮0.15~0.40%。
3.根据权利要求1所述的一种治疗哮喘中西药及制备方法,其制备方法为:
①按比例取西药:甘草片、扑尔敏、安茶碱、新诺明、肺宝三效和强的松精研成粉;
②加入酵母和适量的水进行发酵;
③按比例取中药:川贝母、桔梗、制麻黄、杏仁和桑白皮精研成粉后加入。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811590232.1A CN109464584A (zh) | 2018-12-25 | 2018-12-25 | 一种治疗哮喘中西药及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811590232.1A CN109464584A (zh) | 2018-12-25 | 2018-12-25 | 一种治疗哮喘中西药及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109464584A true CN109464584A (zh) | 2019-03-15 |
Family
ID=65677257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811590232.1A Pending CN109464584A (zh) | 2018-12-25 | 2018-12-25 | 一种治疗哮喘中西药及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109464584A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1179976A (zh) * | 1997-10-12 | 1998-04-29 | 殷清成 | 根治呼吸系统疾病的化痰平喘净 |
CN1256942A (zh) * | 1999-11-10 | 2000-06-21 | 王守东 | 一种治疗咳喘的药物组合物及其制备方法 |
CN1333054A (zh) * | 2000-12-26 | 2002-01-30 | 高守荣 | 止咳平喘药剂 |
CN1562317A (zh) * | 2004-04-19 | 2005-01-12 | 李文章 | 一种止咳平喘的药物 |
CN107669936A (zh) * | 2017-11-20 | 2018-02-09 | 北京煜煌科技有限公司 | 一种儿科治疗哮喘的药物及其制备方法 |
-
2018
- 2018-12-25 CN CN201811590232.1A patent/CN109464584A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1179976A (zh) * | 1997-10-12 | 1998-04-29 | 殷清成 | 根治呼吸系统疾病的化痰平喘净 |
CN1256942A (zh) * | 1999-11-10 | 2000-06-21 | 王守东 | 一种治疗咳喘的药物组合物及其制备方法 |
CN1333054A (zh) * | 2000-12-26 | 2002-01-30 | 高守荣 | 止咳平喘药剂 |
CN1562317A (zh) * | 2004-04-19 | 2005-01-12 | 李文章 | 一种止咳平喘的药物 |
CN107669936A (zh) * | 2017-11-20 | 2018-02-09 | 北京煜煌科技有限公司 | 一种儿科治疗哮喘的药物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102488882B (zh) | 一种治疗猪呼吸道疾病综合征的复方蜂胶组合物及其制备方法 | |
CN103638488B (zh) | 一种治疗胸膜炎的中药组合物 | |
CN103845407A (zh) | 一种治疗乳糜胸的中药 | |
CN104306793B (zh) | 一种治疗大叶性肺炎的中药制剂 | |
CN109464584A (zh) | 一种治疗哮喘中西药及制备方法 | |
CN103933437A (zh) | 一种治疗哮喘的中药组合物及其制备方法 | |
CN107823600A (zh) | 治疗小儿寒性咳嗽的中药制剂 | |
CN103463517B (zh) | 治疗哮喘的药物 | |
CN102961630B (zh) | 一种利用鸡肫草治疗支气管炎的中药 | |
CN102961570B (zh) | 一种治疗风热犯肺型支气管炎的中药 | |
CN104998080A (zh) | 一种用于治疗咳嗽变异性哮喘的中药组合物 | |
CN105641377A (zh) | 治疗猪支气管肺炎的中药煎煮液及其制备方法 | |
CN110064033A (zh) | 一种止咳化痰凝血的药物组合物及其制备方法 | |
CN109674847A (zh) | 一种用于治疗咳喘的雾化药物组合物及其制备方法 | |
CN103463518B (zh) | 一种止咳平喘的药物 | |
CN102430115B (zh) | 一种治疗猪圆环病毒病的复方蜂胶组合物及其制备方法 | |
CN103223157B (zh) | 一种用于治疗感冒的中药组合物 | |
CN105362548A (zh) | 一种治疗过敏性哮喘的中药 | |
CN103751743A (zh) | 一种治疗慢性阻塞性肺病的中药丸及其制作方法 | |
CN105816836A (zh) | 一种治疗间质性肺炎的中药制剂及其应用 | |
CN105797096A (zh) | 一种穴位咳喘贴 | |
CN104258361A (zh) | 一种治疗小儿哮喘的中药组合物 | |
CN104161835A (zh) | 一种治疗痰热咳嗽的中药 | |
CN104398941A (zh) | 一种用于治疗长期干咳的中药组合物 | |
CN103638433B (zh) | 一种治疗胸膜炎的纯中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190315 |
|
RJ01 | Rejection of invention patent application after publication |